ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Vaccination"

  • 2016 American Transplant Congress

    One Year Post VZV Booster: Still Equal Response in Renal Transplant Recipients Compared to Healthy Persons.

    M. Kho,1 W. Weimar,1 M. Boer-Verschragen,1 A. van der Eijk,2 N. van Besouw.1

    1Internal Medicine - Nephrology and Transplantation, Erasmus Medical Center, Rotterdam, Netherlands; 2Viroscience, Erasmus Medical Center, Rotterdam, Netherlands.

    Introduction: Herpes zoster occurs more frequently and with more complications in solid organ transplant recipients than in age matched healthy persons. Vaccination could prevent herpes…
  • 2015 American Transplant Congress

    Antibody Response Following Influenza Vaccination in Renal Transplant Recipients

    M. Mujtaba, B. Book, A. Sharfuddin, A. Khalil, S. Vaishnav, E. Wiebke, M. Yaqub, D. Mishler, T. Taber.

    Indiana University School of Medicne-IU Health, Indianapolis, IN.

    Purpose: Following the recommended consensus guidelines of ATC for vaccination, at our institution we recommend annual vaccination for influenza + H1N1 (Flu) for renal transplant…
  • 2015 American Transplant Congress

    Primary and Secondary Vaccine Responses in a Non-Human Primate Model of Cardiac Allotransplantation

    S. Dahi,1 E. Kang,1 T. Zhang,1 B. Vanhove,2 A. Azimzadeh,1 R. Pierson III.1

    1Department of Surgery, University of Maryland School of Medicine, Baltimore, MD; 2INSERM, Nantes, France.

    Purpose: To compare the effect of calcineurin- versus costimulation-based immunosuppression on primary and secondary vaccine responses in non-human primate heart transplant recipients.Background: Antibody response following…
  • 2015 American Transplant Congress

    Early Antibody Mediated Rejection in HLA Antibody Incompatible Kidney Transplantation – A Treatable Condition Without Heavy Induction Immunosuppression

    S. Daga,1,2 N. Krishnan,1 D. Lowe,3 F. Lam,1 C. Imray,1,2 H. Kashi,1 L. Tan,1 D. Briggs,3 R. Higgins.1,2

    1Renal Department, University Hospital, Coventry, United Kingdom; 2Warwick Medical School, University of Warwick, Coventry, United Kingdom; 3H&I Department, NHSBT, Birmingham, United Kingdom.

    Transplantation across preformed donor specific HLA antibodies (DSA) not only carries a risk of early acute antibody mediated rejection (AMR) and graft loss, but also…
  • 2015 American Transplant Congress

    Outbreak of Pandemic Influenza A (H1N1pdm) in a Kidney Transplant Unit – The Protective Effect of Vaccination

    I. Helanterä,1 V.-J. Anttila,2 M. Lappalainen,3 M. Lempinen,1 H. Isoniemi.1

    1Department of Transplant and Liver Surgery, Helsinki University Central Hospital, Helsinki, Finland; 2Department of Infectious Diseases, Helsinki University Central Hospital, Helsinki, Finland; 3Department of Virology, Helsinki University Central Hospital, Helsinki, Finland.

    Background: Seasonal influenza vaccination is recommended for patients with end-stage renal disease, although the efficacy of the vaccination among these patients is unknown. We characterize…
  • 2015 American Transplant Congress

    Heterologous Immune Responses to Influenza Vaccine in Kidney Transplant Recipients

    D. Kumar,1 P. Campbell,2 K. Hoschler,3 A. Humar.1

    1Univ Health Network, Toronto, Canada; 2Univ of Alberta, Edmonton, Canada; 3Public Health England, London, United Kingdom.

    Background:Influenza vaccine is known to have suboptimal immunogenicity in transplant recipients. However, influenza vaccine may have the added benefit of inducing a cross-reactive immune response…
  • 2015 American Transplant Congress

    Assessing Pre-Vaccination Cytokine Levels to Predict Immunogenicity to Seasonal Trivalent Influenza Vaccine in Solid Organ Transplant Recipients

    M. Fernandez-Ruiz, A. Humar, S. Keshwani, S. Husain, D. Kumar.

    Multi-Organ Transplant Program, University Health Network, Toronto, Canada.

    Background: The immunogenicity of seasonal trivalent influenza vaccine (TIV) in solid organ transplant (SOT) recipients remains suboptimal. We hypothesized that analysis of pre-vaccination T- and…
  • 2015 American Transplant Congress

    Vaccine Responses in Combined Hematopoeitic Stem Cell-Kidney Transplant Recipients

    C. Feng,1 M. Ison,1 J. Galvin,1 S. Ildstad,2,3 D. Stare,1 J. Leventhal.1

    1Northwestern University, Chicago, IL; 2University of Louisville, Louisville, KY; 3Regenerex, LLC, Louisville, KY.

    Background: Vaccines remain one of the most effective methods of preventing infections following transplantation. Data suggests that vaccine responses are reduced in recipients of hematopoeitic…
  • 2015 American Transplant Congress

    Suboptimal Vaccination Coverage After Liver Transplantation: Opportunity for Improvement

    L. Danziger-Isakov, S. Blum, G. Paulsen, M. Lake, R. Rengering, M. Duncan, J. Zigmond, K. Campbell, J. Bucuvalas.

    Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

    Elimination of vaccine-preventable disease after solid organ transplantation (SOT) has the potential to improve outcomes. We evaluated immunization rates and the impact of directed recommendations…
  • 2015 American Transplant Congress

    Boosting the Adaptive Immune Response Prevents the High Incidence of Herpes Zoster After Lung or Heart Transplantation

    N. van Besouw,1 S. Roest,2 J. Zuijderwijk,1 R. de Kuiper,1 J. van Weezel,3 A. van der Eijk,4 W. Weimar,1 P. Hal,3 O. Manintveld.2

    1Internal Medicine - Transplantation, Erasmus MC, Rotterdam, Netherlands; 2Cardiology, Erasmus MC, Rotterdam, Netherlands; 3Respiratory Medicine, Erasmus MC, Rotterdam, Netherlands; 4Viroscience, Erasmus MC, Rotterdam, Netherlands.

    Purpose Primary varicella zoster virus (VZV) infection causes varicella and lifelong latent infection in ganglia from which it may reactivate leading to herpes zoster (HZ).…
  • « Previous Page
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences